Cherrydale Wealth Management, LLC Johnson & Johnson Transaction History

Cherrydale Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$155.22 - $162.74 $272,255 - $285,445	1,754 New	1,754 $277,000
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $34,732 - $38,909	-223 Reduced 11.34%	1,743 $271,000
Q2 2023 Jul 17, 2023	BUY	$154.35 - $166.11 $97,240 - $104,649	630 Added 47.16%	1,966 $325,000
Q1 2023 Apr 14, 2023	SELL	$151.05 - $180.26 $47,731 - $56,962	-316 Reduced 19.13%	1,336 $207,000
Q4 2022 Jan 18, 2023	BUY	$160.2 - $179.79 $37,326 - $41,891	233 Added 16.42%	1,652 $0
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $4,517 - $5,026	28 Added 2.01%	1,419 $232,000
Q2 2022 Jul 07, 2022	BUY	$168.19 - $186.01 $13,959 - $15,438	83 Added 6.35%	1,391 $247,000
Q1 2022 Apr 26, 2022	BUY	$158.14 - $179.59 $8,223 - $9,338	52 Added 4.14%	1,308 $231,000
Q4 2021 Feb 01, 2022	BUY	$155.93 - $173.01 $195,848 - $217,300	1,256 New	1,256 $215,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Cherrydale Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cherrydale Wealth Management, LLC with notifications on news.